The two registration paths for skincare, which product types land on each, and how to register once you know your path.
| Cosmetic path (MoCRA) | Drug path (OTC drug) | |
|---|---|---|
| When | Cleanses / improves appearance | Treats a condition or affects structure/function |
| Register | Facility registration (Cosmetics Direct, FEI) | Drug establishment registration (Part 207) |
| List | Cosmetic product listing (each product) | NDC drug listing (SPL) |
| Label | Cosmetic label (INCI, RP contact) | Drug Facts panel |
| Basis | MoCRA | OTC monograph or an NDA |
| Renewal | Biennial | Annual (Oct–Dec) |
| Foreign | U.S. Agent required | U.S. Agent required |
| Usually a cosmetic (MoCRA) | Commonly a drug (drug pathway) |
|---|---|
| Cleansers, moisturizers, creams & lotions | Sunscreen / SPF products |
| Serums, toners, essences | Acne treatments (salicylic acid, benzoyl peroxide) |
| Masks, exfoliants (appearance claims) | Anti-aging with structure/function claims (collagen, barrier repair) |
| Eye creams (no drug claims), body care | Skin lighteners (hydroquinone — unapproved OTC new drugs) |
For skincare that's a cosmetic — the majority — the steps are:
If your skincare makes a drug claim or uses a drug active, it's an OTC drug — a heavier path:
FDA Registration Assistance starts by confirming your path — reviewing your skincare's claims and ingredients to determine whether it's a cosmetic (MoCRA) or a drug — then handles the right registration: facility registration and product listing (with Responsible Person, U.S. Agent, safety, and labeling) for cosmetics, or drug establishment registration, NDC listing, and Drug Facts for medicated products.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.
Most do - but which registration depends on what the product is. Skincare that cleanses or improves appearance (cleansers, moisturizers, serums, toners, masks) is a cosmetic and registers under MoCRA: facility registration, product listing, a Responsible Person, safety substantiation, adverse-event reporting, and labeling (foreign facilities also need a U.S. Agent). Skincare that treats a condition or affects the skin's structure/function is an OTC drug and registers on the drug pathway instead. So the first step is classification - it decides which registration applies.
By the claims. Appearance and cleansing claims ("moisturizes," "reduces the appearance of wrinkles," "improves the look of skin") keep it a cosmetic. Claims to treat a condition or affect the body's structure/function ("treats acne," "protects from sunburn/SPF," "stimulates collagen," "repairs the barrier," "lightens hyperpigmentation") make it an OTC drug. The same base cream can be either, depending on how it's marketed - so settle this before you register, because it decides the whole path.
For skincare that's a cosmetic: register the manufacturing facility with FDA (via Cosmetics Direct, with an FEI, and a U.S. Agent if foreign), list each product, designate a Responsible Person, maintain safety substantiation, set up adverse-event reporting, and use compliant labeling. Facility registration renews every two years and listings update annually. This is the path most skincare brands are on. See our serums/creams/lotions and cosmetics registrar guides for the detail.
If your skincare makes a drug claim or uses a drug active (sunscreen/SPF, acne actives like salicylic acid or benzoyl peroxide, hydroquinone lighteners), it's an OTC drug and follows the drug pathway: drug establishment registration, an NDC listing, a Drug Facts label, an applicable OTC monograph (or an approved NDA), cGMP, OMUFA fees, and a U.S. Agent for foreign firms. It's a heavier path than the cosmetic one, which is why classification matters so much. See our "do skincare products need FDA drug registration" guide.
The bulk of the category: cleansers, moisturizers, creams and lotions, serums, toners, face masks, exfoliants (with appearance claims), eye creams (without drug claims), and general body care. These are cosmetics under MoCRA when they're marketed to cleanse or improve appearance. They tip into drug territory only when the claims or actives cross the line - which is where a claims review pays off.
Sunscreen and SPF products (sun protection is a drug claim); acne treatments (salicylic acid, benzoyl peroxide); anti-aging products that claim to affect the skin's structure/function (stimulate collagen, repair the barrier); and skin-lightening products (hydroquinone lighteners are actually unapproved OTC new drugs). These follow the drug pathway - or, for anti-aging structure/function claims, would need an NDA since there's no anti-aging monograph.
No - not cosmetics (color additives are the exception), and OTC drugs are "compliance, not approval" unless they go the NDA route. So neither MoCRA registration for a cosmetic skincare product nor OTC drug registration for a medicated one is FDA "approval." Registration puts you in FDA's system and makes you compliant; claiming your skincare is "FDA-approved" because it's registered is misleading.
Yes. Any skincare marketed in the U.S. must comply regardless of where it's made. On the cosmetic path, the foreign facility registers and designates a U.S. Agent; on the drug path, the foreign drug establishment registers and designates a U.S. Agent too (under the drug rules). Home-country cosmetic approval doesn't transfer. Foreign skincare brands should confirm the path and map the roles before entering the U.S.
On the cosmetic path, yes - each product is listed with FDA (and shades/variants that differ in formulation reflected in the listings), updated at least annually. On the drug path, each product is listed with an NDC. Either way, listing is at the product level, so a full skincare line means multiple listings, and a common mistake is registering the facility but not listing all the products.
Cosmetic skincare needs a Principal Display Panel (statement of identity, net quantity) and an information panel (INCI ingredient list, responsible-party address, warnings, and the MoCRA adverse-event contact), with no drug claims or "FDA Approved." Drug skincare needs a Drug Facts panel instead. The label has to match the classification and the listing - a frequent failure point on both paths.
On the cosmetic path, yes - a limited one: businesses under $1 million in average annual U.S. cosmetic sales over the prior three years can be exempt from facility registration and product listing, but not for products that contact the eye's mucous membrane, are injected, are for internal use, or alter appearance for more than 24 hours, and never from safety, adverse-event, or labeling duties. The drug path has no equivalent small-business exemption.
On the cosmetic path, the Responsible Person must report serious adverse events to FDA within 15 business days and keep records for six years (three for small businesses). For skincare, serious events can include severe irritation, allergic reactions, or infections. A reporting process should be in place before you sell, and even small brands exempt from registration/listing are not exempt from adverse-event reporting.
On the cosmetic path, facility registration renews every two years (biennially), and listings update at least annually. On the drug path, drug establishment registration renews annually (October–December). Keeping registration current is part of staying eligible to sell - a lapse can hold shipments or create import problems for your skincare line, on either path.
Building compliance on the wrong path (treating a drug as a cosmetic, or vice versa); drug claims on a cosmetic skincare label; registering the facility but not listing all products; thin safety substantiation for water-based products; missing the U.S. Agent (foreign); and "FDA approved" claims. Nearly all trace back to not settling the cosmetic-vs-drug classification first - which is the single most important step.
Yes. An SPF moisturizer is the classic example - it moisturizes (cosmetic) and protects from the sun (drug), so it carries both sets of obligations. A "both" product is on the drug pathway for its drug aspects, and you confirm the full set of requirements based on the combination. Getting the classification right up front is what tells you whether you're on one path or both.
We start by confirming the path - reviewing your skincare's claims and ingredients to determine whether it's a cosmetic (MoCRA) or a drug - then handle the right registration: facility registration and product listing (with Responsible Person, U.S. Agent, safety, and labeling) for cosmetics, or drug establishment registration, NDC listing, and Drug Facts for medicated products. We're an independent compliance firm serving 1,000+ companies across 135+ countries with 15+ years of experience. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.